These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32504862)

  • 1. Comparative Study of Mizoribine and Mycophenolate Mofetil Combined with a Calcineurin Inhibitor-Based Immunosuppressive Regimen in Patients with Alternative Donor Hematopoietic Cell Transplantation.
    Huang Y; Han M; Yang D; Zhang R; Ma Q; Pang A; Zhai W; He Y; Wei J; Jiang E; Feng S; Zhang L
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1663-1669. PubMed ID: 32504862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy and safety of mizoribine with mycophenolate mofetil for Asian renal transplantation--a meta-analysis.
    Xing S; Yang J; Zhang X; Zhou P
    Clin Biochem; 2014 May; 47(7-8):663-9. PubMed ID: 24463228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.
    Chhabra S; Liu Y; Hemmer MT; Costa L; Pidala JA; Couriel DR; Alousi AM; Majhail NS; Stuart RK; Kim D; Ringden O; Urbano-Ispizua A; Saad A; Savani BN; Cooper B; Marks DI; Socie G; Schouten HC; Schoemans H; Abdel-Azim H; Yared J; Cahn JY; Wagner J; Antin JH; Verdonck LF; Lehmann L; Aljurf MD; MacMillan ML; Litzow MR; Solh MM; Qayed M; Hematti P; Kamble RT; Vij R; Hayashi RJ; Gale RP; Martino R; Seo S; Hashmi SK; Nishihori T; Teshima T; Gergis U; Inamoto Y; Spellman SR; Arora M; Hamilton BK
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):73-85. PubMed ID: 30153491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.
    Bejanyan N; Rogosheske J; DeFor TE; Lazaryan A; Arora M; Holtan SG; Jacobson PA; MacMillan ML; Verneris MR; Blazar BR; Weisdorf DJ; Wagner JE; Brunstein CG
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2025-2030. PubMed ID: 27519278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of High-Dose Mizoribine Combined With Cyclosporine, Basiliximab, and Corticosteroids in Renal Transplantation: A Japanese Multicenter Study.
    Ushigome H; Uchida K; Nishimura K; Akioka K; Fukuda Y; Yuzawa K; Fujisawa M; Sugitani A; Ito SI; Nakatani T; Horimi T; Yoshimura N
    Transplant Proc; 2016 Apr; 48(3):794-8. PubMed ID: 27234738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
    Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparative trial of mizoribine versus mycophenolate mofetil in combination with tacrolimus for living donor renal transplantation.
    Takahara S; Takahashi K; Akiyama T; Uchida K; Tanabe K; Amada N; Toma H
    Clin Exp Nephrol; 2013 Dec; 17(6):899-904. PubMed ID: 23430390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality.
    Sabry W; Le Blanc R; Labbé AC; Sauvageau G; Couban S; Kiss T; Busque L; Cohen S; Lachance S; Roy DC; Roy J
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):919-29. PubMed ID: 19589481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment.
    Yoshimura N; Ushigome H; Matsuyama M; Nobori S; Suzuki T; Sakai K; Okajima H; Okamoto M
    Transplant Proc; 2012 Jan; 44(1):140-3. PubMed ID: 22310599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Mizoribine and Mycophenolate Mofetil With a Tacrolimus-Based Immunosuppressive Regimen in Living-Donor Kidney Transplantation Recipients: A Retrospective Study in China.
    Shi Y; Liu H; Chen XG; Shen ZY
    Transplant Proc; 2017; 49(1):26-31. PubMed ID: 28104150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil.
    Sakatoku K; Kim SW; Okamura H; Kanaya M; Kato K; Yamasaki S; Uchida N; Kobayashi H; Fukuda T; Takayama N; Ishikawa J; Nakazawa H; Sakurai M; Ikeda T; Kondo T; Yoshioka S; Miyamoto T; Kimura T; Ichinohe T; Atsuta Y; Kondo E
    Ann Hematol; 2022 Dec; 101(12):2743-2757. PubMed ID: 36195679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcineurin inhibitor--free graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide and brief-course sirolimus following reduced-intensity peripheral blood stem cell transplantation.
    Solomon SR; Sanacore M; Zhang X; Brown S; Holland K; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1828-34. PubMed ID: 25064745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
    Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R
    Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation.
    Hamad N; Shanavas M; Michelis FV; Uhm J; Gupta V; Seftel M; Kuruvilla J; Lipton JH; Messner HA; Kim DD
    Am J Hematol; 2015 May; 90(5):392-9. PubMed ID: 25615933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness and safety of high-dose mizoribine on ABO-incompatible living related kidney transplantation using anti-CD20 and anti-CD25 antibodies without splenectomy: 3-year results.
    Yoshimura N; Ushigome H; Nobori S; Suzuki T; Sakai K; Koshino K; Nakamura T; Nakao T; Harada S; Ito T
    Transplant Proc; 2014; 46(2):391-4. PubMed ID: 24655971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Mizoribine Combined With Tacrolimus in Living Donor Kidney Transplant Recipients: 3-Year Results by a Chinese Single Center Study.
    Shi Y; Liu H; Chen XG; Shen ZY
    Transplant Proc; 2019 Jun; 51(5):1337-1342. PubMed ID: 31155174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Pilot Study of Continuous Infusion of Mycophenolate Mofetil for Prophylaxis of Graft-versus-Host-Disease in Pediatric Patients.
    Windreich RM; Goyal RK; Joshi R; Kenkre TS; Howrie D; Venkataramanan R
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):682-689. PubMed ID: 26740371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single cord blood transplantation for acute myeloid leukemia patients aged 60 years or older: a retrospective study in Japan.
    Isobe M; Konuma T; Masuko M; Uchida N; Miyakoshi S; Sugio Y; Yoshida S; Tanaka M; Matsuhashi Y; Hattori N; Onizuka M; Aotsuka N; Kouzai Y; Wake A; Kimura T; Ichinohe T; Atsuta Y; Yanada M;
    Ann Hematol; 2021 Jul; 100(7):1849-1861. PubMed ID: 33624134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMT.
    Paviglianiti A; Labopin M; Blaise D; Socié G; Bulabois CE; Lioure B; Ceballos P; Blau IW; Guillerm G; Maertens J; Chevallier P; Huynh A; Turlure P; Deconinck E; Forcade E; Nagler A; Mohty M
    Bone Marrow Transplant; 2021 May; 56(5):1077-1085. PubMed ID: 33249424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Efficacy and Safety of Mizoribine versus Mycophenolate Mofetil for the Treatment of Renal Transplantation: A Systematic Review and Meta-Analysis.
    Chen J; Liu H; Yin W; Xu Z; Chen Z; Yiu W
    Comput Intell Neurosci; 2022; 2022():5717068. PubMed ID: 35909831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.